BREAKING: Capricor Therapeutics Sued For Securities Fraud; Investors Should Contact Block & Leviton to Potentially Recover Losse

  • Block & Leviton announces that a securities fraud lawsuit has been filed against Capricor Therapeutics (Nasdaq: CAPR). Investors should contact the firm.